Health in Tech, INC

Health In Tech, Inc. published an updated investor presentation detailing its AI-powered marketplace platform for self-funded health plans.

Health In Tech announced its first quarter 2026 financial results, showing a 9.4% revenue increase to $8.8 million, while reiterating its full-year revenue guidance of $45 million to $50 million.

Dustin Plantholt departs as Chief AI & Marketing Officer, transitioning to an independent consulting role.

Health In Tech, Inc. presented its AI-powered marketplace platform for self-funded health plans, reporting strong 2025 financial results and optimistic 2026 revenue guidance.

Health In Tech, an AI-enabled InsurTech platform company, announced the closing of a $7.0 million private investment in public equity financing to fund strategic growth initiatives.

Health In Tech, an AI-enabled InsurTech platform, announced a $7.0 million private placement of common stock to fund sales expansion and technology development.

Health In Tech reported a 9.4% year-over-year revenue increase to $8.8 million for Q1 2026, driven by its SMR segment, but experienced a widening net loss of $1.6 million.

Health In Tech, Inc. announced significant revenue growth and strategic technology advancements in its Q3 2025 report, despite a temporary pause in its HI Card service.

Health In Tech, Inc. announced significant revenue and profit growth for the first half of 2025, driven by new product demand and increased enrolled employees.

Health In Tech's Q1 2025 shows significant revenue growth driven by new product offerings and expanded adoption of self-funded health plan solutions.

Health In Tech, Inc. announced robust financial performance for fiscal year 2025, driven by significant revenue growth and expanded platform adoption, despite pausing HI Card development.

Health In Tech's 2024 10-K filing highlights a profitable year with a 2% revenue increase, driven by strategic shifts and AI-powered platforms.

Zain Syed Hasan, Chief Growth Officer of Health In Tech, Inc., reported a transaction in 4,084 shares of common stock on July 15, 2026.

Tim Donald Johnson, Chief Executive Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 47,217 shares of common stock on July 15, 2026.

Linlin Qian, Chief Financial Officer, a Director and 10% owner of Health In Tech, Inc., reported a transaction in 28,725 shares of common stock on July 15, 2026.

Health In Tech, Inc. director Sanjay K. Shrestha has executed a Power of Attorney, authorizing specific individuals to manage SEC filings related to his securities ownership and transactions.

Health In Tech, Inc. director William D. Howard has executed a Power of Attorney authorizing specific individuals to handle SEC filings related to securities ownership and transactions.

Health In Tech, Inc. director Timothy Hayes has executed a Power of Attorney, authorizing specific individuals to manage SEC filings related to his securities ownership and transactions.

Health In Tech announced it will host its 2025 Annual Stockholder Meeting virtually on October 3, 2025, for shareholders of record as of August 6, 2025.

Health In Tech, Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, an expanded equity incentive plan, and auditor ratification.

Health In Tech, Inc. has filed an amendment to its S-1 registration statement, primarily to update the consent of its independent auditor, MaloneBailey, LLP.

Health In Tech, Inc. has filed an amendment to its S-1 registration statement, detailing a proposed public offering of 2,300,000 shares of Class A Common Stock and a resale of 1,969,585 shares by a selling shareholder.

Health In Tech, Inc. has filed Amendment No. 4 to its Form S-1 registration statement for a proposed IPO of 2,300,000 shares of Class A Common Stock and the potential resale of 1,969,585 shares by a selling shareholder.

Health In Tech, Inc. has filed Amendment No. 3 to its Form S-1 registration statement with the SEC, primarily focusing on exhibits and legal opinions related to the offering of Class A common stock.

Health In Tech, Inc. has filed an amendment to its Form S-1 registration statement, outlining details for a proposed initial public offering of Class A Common Stock and a resale prospectus.

Health In Tech, an insurance technology platform, is seeking to raise capital through an initial public offering (IPO) to fund system enhancements, business expansion, and sales growth, aiming for a Nasdaq listing under the symbol HIT.

Zhong Yang Securities Limited has filed an amended Schedule 13G, clarifying that it holds no beneficial ownership in Health In Tech, Inc.'s Class A Common Stock.

LinLin Qian, an individual, has disclosed a beneficial ownership of 24.4% of Health In Tech, Inc.'s Class A Common Stock as of December 31, 2024, comprising a mix of common shares, restricted stock, Class B shares, and stock options.

Tim Johnson, a key individual at Health In Tech, Inc., has disclosed a significant beneficial ownership stake of 60.4% in the company's Class A Common Stock following its recent initial public offering.

Zhong Yang Securities Limited has reported a 9.3% beneficial ownership stake in Health In Tech, Inc.'s Class A Common Stock as of December 31, 2024.